IMMUCELL CORP /DE/
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 56 EVERGREEN DR, PORTLAND, ME, 04103
Mailing Address 56 EVERGREEN DRIVE, PORTLAND, ME, 04103
Phone 2078782770
Fiscal Year End 1231
EIN 010382980
Financial Overview
FY2024
$45.10M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 8-K Current report of material events | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 8-K Current report of material events | December 29, 2025 | View on SEC |
| 4/A Insider transaction amendment | December 4, 2025 | View on SEC |
| 4 Insider stock transaction report | December 3, 2025 | View on SEC |
| 4 Insider stock transaction report | November 28, 2025 | View on SEC |
Insider Trading
BUY 2 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
QuidelOrtho Corp
QDEL In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
IDEXX LABORATORIES INC /DE
IDXX In Vitro & In Vivo Diagnostic Substances
VOLITIONRX LTD
VNRX In Vitro & In Vivo Diagnostic Substances
NEOGEN CORP
NEOG In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.